Key result
TAVR combined with PCI increased the risk of early permanent pacemaker implantation compared to SAVR with CABG.
Why the study?
In patients with concomitant severe aortic stenosis and coronary artery disease, TAVR + PCI has not been sufficiently compared to SAVR + CABG regarding conduction disturbances and long-term outcomes.
Does TAVR + PCI increase the risk of conduction disturbances and permanent pacemaker implantation compared to SAVR + CABG in patients with severe aortic stenosis and coronary artery disease?
Cohort (n=120)
No
Does TAVR + PCI increase the risk of conduction disturbances and permanent pacemaker implantation compared to SAVR + CABG in patients with severe aortic stenosis and coronary artery disease?
In patients with severe aortic stenosis and coronary artery disease, a fully percutaneous approach (TAVR + PCI) significantly increases the risk of early conduction disturbances and the need for permanent pacemaker implantation compared to surgery (SAVR + CABG), without a significant difference in median survival.
Answers are grounded in this paper and cite their sources.
May warrant caution selecting TAVR+PCI; leaves open conduction risk pending randomized confirmation in AS+CAD.
Conduction disturbances, including bundle branch and atrioventricular blocks, are frequent after aortic valve replacement and may require permanent pacemaker implantation (PPI). In patients with concomitant severe aortic stenosis and coronary artery disease, the fully percutaneous approach (TAVR + PCI) has not been sufficiently compared to SAVR + CABG regarding conduction disturbances and long-term outcomes. A total of 1,232 patients undergoing either TAVR + PCI or SAVR + CABG between January 2010 and December 2020 were retrospectively evaluated. Propensity score matching (1:1) was performed based on eight baseline variables to reduce confounding. The final matched cohort included 120 patients (60 per group) with comparable demographic profiles and intermediate surgical risk. The TAVR + PCI group exhibited significantly higher rates of in-hospital conduction disturbances (26.7% vs. 6.7%; p = 0.006) and early (30-day) permanent pacemaker implantation (PPI) (16.7% vs. 5.0%; p = 0.039; OR, 3.8; 95% CI, 0.01–2.68). During follow-up, a higher incidence of atrioventricular block was observed in the TAVR + PCI group (28% vs. 12%; p = 0.011), accompanied by a non-significant trend toward increased bundle branch blocks (22% vs. 10%; p = 0.132) and late PPI (11.7% vs. 8.3%; sub-HR, 1.42; 95% CI, − 0.90 to 1.60; p = 0.583). Median survival did not differ significantly between groups (5.55 vs. 4.05 years; HR, 0.77; 95% CI, 0.44–1.32; p = 0.312). Compared to SAVR + CABG, the TAVR + PCI strategy is associated with a significantly increased risk of early conduction disturbances and PPI. These findings highlight the relevance of conduction system vulnerability in therapeutic decision-making for patients with combined valvular and coronary pathology
No takes yet. Share an insight, caveat, or question.
Taghiyev et al. (2026) conducted a cohort in Severe aortic stenosis and coronary artery disease (n=120). TAVR + PCI vs. SAVR + CABG was evaluated on Early (30-day) permanent pacemaker implantation (PPI) (OR 3.8, 95% CI 0.01-2.68, p=0.039). TAVR combined with PCI increased the risk of early permanent pacemaker implantation compared to SAVR with CABG.
Synapse has enriched 10 related papers. Consider them for comparative context: